Veru (VERU) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 6, 2023 (05:41)
Sector: Consumer defensiveThe share price of Veru Inc. (VERU) now
50/200 Day Moving Average: $0.893 / $1.35
This figure corresponds to the Average Price over the previous 50/200 days. For Veru stocks, the 50-day moving average is the support level today.
For Veru stocks, the 200-day moving average is the resistance level today.
Are you interested in Veru Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Veru stock price in 2023, 2024, 2025, 2026, 2027. How much will one Veru share be worth in 2023 - 2027?
When should I take profit in Veru stock? When should I record a loss on Veru stock? What are analysts' forecasts for Veru stock? What is the future of Veru stock? We forecast Veru stock performance using neural networks based on historical data on Veru stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Veru stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Veru shares. This happens once a day.
Historical and forecast chart of Veru stock
The chart below shows the historical price of Veru stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Veru stock price can be found in the table below.
Long-term forecasts by years.
Veru Inc. is an oncology and urology biopharmaceutical company specializing in the development of drugs for the treatment of prostate cancer. The company operates in two segments: Commercial and Research and Development. The commercial segment consists of FC2. The R&D segment consists of several drugs in clinical development for oncology and urology. The company’s prostate cancer pipeline includes VERU-111, VERU-100, and zuclomiphene citrate. VERU-111 is an oral chemical that targets, cross-links, and disrupts alpha and beta tubulin microtubule subunits. VERU-100 is a peptide formulation designed to address the limitations of commercially available treatments for androgen deprivation (ADT) in advanced prostate cancer. The company’s commercial products include the FC2 Female Condom/FC2 Internal Condom (FC2), a product to protect against unintended pregnancy and sexually transmitted infections.
Veru daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 08 | 1.02 | 1.00 | 1.05 | 4.70 |
| Dec 09 | 1.04 | 1.01 | 1.05 | 3.64 |
| Dec 10 | 0.99 | 0.96 | 1.03 | 7.04 |
| Dec 11 | 0.96 | 0.93 | 0.99 | 6.16 |
| Dec 12 | 0.98 | 0.97 | 1.00 | 3.44 |
| Dec 13 | 1.02 | 0.99 | 1.06 | 6.94 |
| Dec 14 | 1.02 | 0.98 | 1.04 | 6.19 |
| Dec 15 | 1.03 | 0.99 | 1.05 | 6.22 |
| Dec 16 | 1.07 | 1.04 | 1.11 | 6.67 |
| Dec 17 | 1.08 | 1.04 | 1.09 | 5.35 |
| Dec 18 | 1.10 | 1.07 | 1.14 | 6.41 |
| Dec 19 | 1.08 | 1.04 | 1.11 | 6.95 |
| Dec 20 | 1.13 | 1.09 | 1.14 | 4.59 |
| Dec 21 | 1.16 | 1.12 | 1.20 | 7.35 |
| Dec 22 | 1.16 | 1.13 | 1.19 | 4.76 |
| Dec 23 | 1.16 | 1.13 | 1.18 | 4.35 |
| Dec 24 | 1.21 | 1.19 | 1.24 | 3.85 |
| Dec 25 | 1.21 | 1.19 | 1.24 | 3.70 |
| Dec 26 | 1.21 | 1.17 | 1.23 | 5.24 |
| Dec 27 | 1.17 | 1.14 | 1.20 | 6.02 |
| Dec 28 | 1.15 | 1.11 | 1.18 | 6.43 |
| Dec 29 | 1.16 | 1.12 | 1.18 | 5.21 |
| Dec 30 | 1.15 | 1.11 | 1.17 | 5.39 |
| Dec 31 | 1.17 | 1.16 | 1.20 | 3.29 |
| Jan 01 | 1.16 | 1.14 | 1.20 | 5.42 |
| Jan 02 | 1.20 | 1.18 | 1.22 | 3.53 |
| Jan 03 | 1.14 | 1.10 | 1.16 | 5.33 |
| Jan 04 | 1.10 | 1.07 | 1.13 | 5.42 |
| Jan 05 | 1.11 | 1.07 | 1.14 | 6.66 |
| Jan 06 | 1.11 | 1.08 | 1.15 | 7.29 |
Veru Daily Price Targets
Veru Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $1.02.
Positive dynamics for Veru shares will prevail with possible volatility of 4.490%.
Pessimistic target level: 1.00
Optimistic target level: 1.05
Veru Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $1.04.
Positive dynamics for Veru shares will prevail with possible volatility of 3.513%.
Pessimistic target level: 1.01
Optimistic target level: 1.05
Veru Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $0.99.
Negative dynamics for Veru shares will prevail with possible volatility of 6.579%.
Pessimistic target level: 0.96
Optimistic target level: 1.03
Veru Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $0.96.
Negative dynamics for Veru shares will prevail with possible volatility of 5.799%.
Pessimistic target level: 0.93
Optimistic target level: 0.99
Veru Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $0.98.
Positive dynamics for Veru shares will prevail with possible volatility of 3.324%.
Pessimistic target level: 0.97
Optimistic target level: 1.00
Veru Stock Forecast 12-13-2023.
Forecast target price for 12-13-2023: $1.02.
Positive dynamics for Veru shares will prevail with possible volatility of 6.491%.
Pessimistic target level: 0.99
Optimistic target level: 1.06
VERU (VERU) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec. | 0.99 | 0.93 | 1.05 | 10.96 |
Veru forecast for this year
Veru Stock Prediction for Dec 2023
An uptrend is forecast for this month with an optimal target price of $0.99003. Pessimistic: $0.93. Optimistic: $1.05
Veru (VERU) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.19 | 1.03 | 1.28 | 19.15 |
| Mar | 1.13 | 1.02 | 1.27 | 19.72 |
| Mar | 1.11 | 0.96 | 1.22 | 21.35 |
| Apr | 0.95 | 0.88 | 1.10 | 20.52 |
| May | 1.14 | 1.04 | 1.25 | 16.55 |
| Jun | 1.35 | 1.25 | 1.49 | 16.00 |
| Jul | 1.47 | 1.41 | 1.55 | 8.92 |
| Aug | 1.43 | 1.32 | 1.57 | 15.88 |
| Sep | 1.53 | 1.32 | 1.75 | 24.69 |
| Oct | 1.62 | 1.54 | 1.71 | 10.06 |
| Nov | 1.31 | 1.17 | 1.52 | 23.32 |
| Dec | 1.27 | 1.13 | 1.44 | 21.65 |
Veru (VERU) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.49 | 1.30 | 1.71 | 24.26 |
| Mar | 1.79 | 1.63 | 1.88 | 13.31 |
| Mar | 1.68 | 1.48 | 1.95 | 23.70 |
| Apr | 1.85 | 1.65 | 2.00 | 17.78 |
| May | 2.21 | 2.05 | 2.36 | 13.32 |
| Jun | 2.26 | 2.00 | 2.41 | 16.89 |
| Jul | 2.21 | 2.04 | 2.53 | 19.41 |
| Aug | 2.02 | 1.70 | 2.17 | 21.93 |
| Sep | 1.96 | 1.66 | 2.12 | 21.44 |
| Oct | 1.94 | 1.82 | 2.24 | 18.69 |
| Nov | 1.89 | 1.70 | 2.04 | 16.70 |
| Dec | 1.83 | 1.64 | 1.91 | 13.82 |
Veru (VERU) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.08 | 1.76 | 2.32 | 24.33 |
| Mar | 2.03 | 1.79 | 2.25 | 20.76 |
| Mar | 2.02 | 1.82 | 2.33 | 22.18 |
| Apr | 1.97 | 1.66 | 2.23 | 25.49 |
| May | 2.03 | 1.76 | 2.20 | 19.93 |
| Jun | 1.94 | 1.82 | 2.08 | 12.29 |
| Jul | 1.79 | 1.64 | 1.90 | 13.58 |
| Aug | 1.67 | 1.51 | 1.82 | 17.25 |
| Sep | 1.80 | 1.66 | 2.00 | 17.12 |
| Oct | 2.14 | 1.96 | 2.26 | 13.26 |
| Nov | 2.11 | 1.83 | 2.26 | 18.88 |
| Dec | 2.48 | 2.27 | 2.72 | 16.64 |
Veru (VERU) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.89 | 2.77 | 3.13 | 11.62 |
| Mar | 3.30 | 2.78 | 3.80 | 26.78 |
| Mar | 3.12 | 2.76 | 3.52 | 21.45 |
| Apr | 2.86 | 2.49 | 3.22 | 22.56 |
| May | 2.84 | 2.50 | 2.98 | 16.00 |
| Jun | 2.61 | 2.36 | 2.94 | 19.72 |
| Jul | 2.82 | 2.62 | 3.18 | 17.58 |
| Aug | 2.89 | 2.62 | 3.05 | 14.20 |
| Sep | 2.94 | 2.53 | 3.36 | 24.83 |
| Oct | 3.30 | 2.99 | 3.72 | 19.54 |
| Nov | 3.10 | 2.76 | 3.56 | 22.61 |
| Dec | 2.90 | 2.48 | 3.18 | 21.90 |
Veru information and performance
2916 N. MIAMI AVENUE, SUITE 1000, MIAMI, FL, UNITED STATES
Market capitalization of the Veru Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of VERU shares in the company outstanding by the market price of one share.
EBITDA of Veru is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Veru (VERU) stock dividend
Veru last paid dividends on 04/28/2014. The next scheduled payment will be on 05/07/2014. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
